Back
Ultragenyx Pharmaceutical Stock Price Chart

7 Stocks to Consider Immediately (must-see chart)
See the green days for 7 major stocks right here, free of charge
Sell
30
RARE
Ultragenyx Pharmaceutical
Last Price:
$41.40
Seasonality Move:
-4.41%
7 Day Trial
ALL ACCESS PASS
$
7

ALERT: Q3 Could Be a Pivotal Quarter for Nasdaq Stocks
Click Here to Download Your FREE Stock Report Now-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RARE is experiencing slight buying pressure.
Ultragenyx Pharmaceutical Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 38.62 | Buy |
20-day SMA: | 37.88 | Buy |
50-day SMA: | 36.9 | Buy |
200-day SMA: | 43.18 | Sell |
8-day EMA: | 16.02 | Buy |
20-day EMA: | 7.34 | Buy |
50-day EMA: | 3.11 | Buy |
200-day EMA: | 0.8 | Buy |
Ultragenyx Pharmaceutical Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.73 | Buy |
Relative Strength Index (14 RSI): | 69.09 | Buy |
Chaikin Money Flow: | 832022 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (36.34 - 39) | Buy |
Bollinger Bands (100): | (34.88 - 40.54) | Buy |
Ultragenyx Pharmaceutical Technical Analysis
Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
25 | 26 | 27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Ultragenyx Pharmaceutical Stock
Is Ultragenyx Pharmaceutical Stock a Buy?
-
Ultragenyx Pharmaceutical share price is 41.44 while RARE 8-day simple moving average is 38.62, which is a Buy signal.
-
The stock price of RARE is 41.44 while Ultragenyx Pharmaceutical 20-day SMA is 37.88, which makes it a Buy.
-
Ultragenyx Pharmaceutical 50-day simple moving average is 36.90 while RARE share price is 41.44, making it a Buy technically.
-
RARE stock price is 41.44 and Ultragenyx Pharmaceutical 200-day simple moving average is 43.18, creating a Sell signal.
RARE Technical Analysis vs Fundamental Analysis
Sell
30
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy or a Sell?
-
Ultragenyx Pharmaceutical stock is rated a SellThe current Ultragenyx Pharmaceutical [RARE] share price is $41.44. The Score for RARE is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
Ultragenyx Pharmaceutical Stock Info
Market Cap:
3.9B
Price in USD:
41.44
Share Volume:
2.7M
Ultragenyx Pharmaceutical 52-Week Range
52-Week High:
60.37
52-Week Low:
29.59
Sell
30
Ultragenyx Pharmaceutical (RARE)
is a Sell
Ultragenyx Pharmaceutical Share Price Forecast
-
What is the Ultragenyx Pharmaceutical stock price today?The Ultragenyx Pharmaceutical stock price is 41.44 USD today.
-
Will RARE stock go up or go down?Ultragenyx Pharmaceutical> share price is forecast to RISE/FALL based on technical indicators
-
Is Ultragenyx Pharmaceutical overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Ultragenyx Pharmaceutical is overvalued.
Is Ultragenyx Pharmaceutical Stock a Buy?
-
Ultragenyx Pharmaceutical share price is 41.44 while RARE 8-day exponential moving average is 16.02, which is a Buy signal.
-
The stock price of RARE is 41.44 while Ultragenyx Pharmaceutical 20-day EMA is 7.34, which makes it a Buy.
-
Ultragenyx Pharmaceutical 50-day exponential moving average is 3.11 while RARE share price is 41.44, making it a Buy technically.
-
RARE stock price is 41.44 and Ultragenyx Pharmaceutical 200-day simple moving average is 0.80, creating a Buy signal.
Fundamental Analysis of Ultragenyx Pharmaceutical
Is Ultragenyx Pharmaceutical a good investment?
-
Analysts estimate an earnings increase this quarter of $0.17 per share, an increase next quarter of $0.37 per share, an increase this year of $0.84 per share, and an increase next year of $1.76 per share.
Technical Analysis of Ultragenyx Pharmaceutical
Should I short Ultragenyx Pharmaceutical stock?
-
RARE Moving Average Covergence Divergence (MACD) indicator is 5.73, suggesting Ultragenyx Pharmaceutical is a Buy
-
Ultragenyx Pharmaceutical Relative Strength Index (RSI) is 69.09, which suggest Ultragenyx Pharmaceutical is overbought
-
The Bollinger Bands (25) for Ultragenyx Pharmaceutical is (36.34 - 39), which suggest Ultragenyx Pharmaceutical is a Buy
-
The Bollinger Bands (100) for Ultragenyx Pharmaceutical is (34.88 - 40.54), which suggest Ultragenyx Pharmaceutical is a Buy
* Ultragenyx Pharmaceutical stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.